コロナワクチン摂取後38.5℃以上出た人は37.5℃以下だった人に比べて抗体価の量が多い。
Yamamoto S, Fukunaga A, Tanaka A, Takeuchi JS, Inoue Y, Kimura M, Maeda K, Ueda G, Mizoue T, Ujiie M, Sugiura W, Ohmagari N. Association between reactogenicity and SARS-CoV-2 antibodies after the second dose of the BNT162b2 COVID-19 vaccine. Vaccine. 2022 Feb 14:S0264-410X(22)00196-7. doi: 10.1016/j.vaccine.2022.02.052. Epub ahead of print. PMID: 35183384; PMCID: PMC8841206.
Yamamoto S, Fukunaga A, Tanaka A, Takeuchi JS, Inoue Y, Kimura M, Maeda K, Ueda G, Mizoue T, Ujiie M, Sugiura W, Ohmagari N. Association between reactogenicity and SARS-CoV-2 antibodies after the second dose of the BNT162b2 COVID-19 vaccine. Vaccine. 2022 Feb 14:S0264-410X(22)00196-7. doi: 10.1016/j.vaccine.2022.02.052. Epub ahead of print. PMID: 35183384; PMCID: PMC8841206.
Yamamoto S, Fukunaga A, Tanaka A, Takeuchi JS, Inoue Y, Kimura M, Maeda K, Ueda G, Mizoue T, Ujiie M, Sugiura W, Ohmagari N. Association between reactogenicity and SARS-CoV-2 antibodies after the second dose of the BNT162b2 COVID-19 vaccine. Vaccine. 2022 Feb 14:S0264-410X(22)00196-7. doi: 10.1016/j.vaccine.2022.02.052. Epub ahead of print. PMID: 35183384; PMCID: PMC8841206.
Yamamoto S, Fukunaga A, Tanaka A, Takeuchi JS, Inoue Y, Kimura M, Maeda K, Ueda G, Mizoue T, Ujiie M, Sugiura W, Ohmagari N. Association between reactogenicity and SARS-CoV-2 antibodies after the second dose of the BNT162b2 COVID-19 vaccine. Vaccine. 2022 Feb 14:S0264-410X(22)00196-7. doi: 10.1016/j.vaccine.2022.02.052. Epub ahead of print. PMID: 35183384; PMCID: PMC8841206.